We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
28 hedge funds and large institutions have $56.1M invested in Arcturus Therapeutics in 2015 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
577% more capital invested
Capital invested by funds: $8.29M → $56.1M (+$47.8M)
0% more funds holding
Funds holding: 28 → 28 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
46% less call options, than puts
Call options by funds: $552K | Put options by funds: $1.01M
Holders
28
Holders Change
–
Holders Change %
0%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
7
Reduced
7
Closed
10
Calls
$552K
Puts
$1.01M
Net Calls
-$463K
Net Calls Change
-$234K
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$9.78M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$9.43M |
| 3 |
VM
VHCP Management
New York
|
+$9.43M |
| 4 |
DM
Deerfield Management
New York
|
+$8.88M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.18M |
